1871 Investors following AstraZeneca. Share this News with them.
0
Like this story, share it with millions of investors on M3
IBEF Research: Wockhardt Limited India
Wockhardt Limited India, established in 1960, is a leading pharmaceuticals and biotechnology company based in India. The company offers products and services formulations, nutritional products and vaccines, active pharmaceutical ingredients, andiopharmaceuticals.
Wockhardt Limited India , established in 1960, is a leading pharmaceuticals and biotechnology company based in India. The company offers products and services formulations, nutritional products and vaccines, active pharmaceutical ingredients, andiopharmaceuticals. It had approximately 3500 employees as on 31 December 2005, of which about 500 employees were working overseas. Wockhardt is the only Indian pharmaceutical company to be given the 'Super Brand' award by the international body 'The Super Brand Council'.
Wockhardt has manufacturing alliances with many leading pharmaceutical companies, such as Aventis , Amylin and Astra Zeneca . It has manufacturing plants in India and the UK, which are certified under USA' USA's FD s FDA and UK' A UK's MHRA.
Wockhardt has a strong global presence with subsidiaries in Brazil, the UK and the USA. The company also has marketing offices in Africa, Russia, and Central and South East Asia. The company's overseas business witnessed a CAGR of 45 per cent during the period 1995-2005.
Wockhardt has been witnessing growth through an inorganic route in Europe. Since 1997, it has acquired three companies in Europe. The acquisition comprises two companies in the UK, C.P. Pharmaceuticals and Wallis Laboratory, and one company in Germany, Esparma GmbH (acquired in 2004).
Wockhardt has a strong global presence with subsidiaries in Brazil, the UK and the USA. The company also has marketing offices in Africa, Russia, and Central and South East Asia. The company's overseas business witnessed a CAGR of 45 per cent during the period 1995-2005.
